Conversely, CYP2E1 and ADH4 exhibited 3.1-fold (p=0.009) and 2.8-fold (p=0.013) decreases in tumor samples, confirming downregulation (Figure 5, Table 1). The gene discussed is CYP2E1; the disease is neoplasm.